Publications
- HPMA-Anticancer Drug Conjugates2009 | First Faculty of Medicine
- New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting2008 | First Faculty of Medicine
- N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation2008 | First Faculty of Medicine
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity2005 | First Faculty of Medicine
- Enzymatically degradable polyurethanes based on poly-ethyene glycol) conjugated with doxorubicin and antibodies in cancer therapyPublication without faculty affiliation
- Different roles of peptide spacers in proteolytically and hydrolytically cleavable HPMA-based polymeric prodrugsPublication without faculty affiliation
- New view on the antitumor properties of HMPA based polymeric prodrugsPublication without faculty affiliation
- Anti-tumour resistance in mice treated with HPMA-based doxorubicin conjugate containing human intravenous immunoglobulin +1Publication without faculty affiliation
- Mistake lasting twenty years? To be in vitro effective doxorubicin does not have to be release from its polymeric HPMA - based carrierPublication without faculty affiliation
- HPMA-based doxorubicin conjugate containing human intravenous immunoglobulins shows anticancer effect and protection of immunityPublication without faculty affiliation
Loading network view...